Literature DB >> 28279462

Screening and Preventive Strategies in Esophagogastric Cancer.

Liam Zakko1, Lori Lutzke2, Kenneth K Wang3.   

Abstract

Gastric adenocarcinoma, esophageal adenocarcinoma, and esophageal squamous cell carcinoma are among the most prevalent and deadly of malignancies worldwide. Screening and prevention programs will be critical to finally improving outcomes in these diseases. For gastric adenocarcinoma, screening in high-risk populations has significantly reduced mortality. More research is needed on screening high-risk individuals in low-risk populations. For esophageal adenocarcinoma, work is needed to develop efficient and effective techniques in mass screening programs. For most Western populations, current screening is not cost effective. Avoiding environmental risk factors is critical to reducing the incidence of this deadly illness.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrett esophagus; Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; Gastric adenocarcinoma; Prevention; Screening

Mesh:

Year:  2017        PMID: 28279462      PMCID: PMC5554862          DOI: 10.1016/j.soc.2016.10.004

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  89 in total

1.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

Review 2.  Epidemiology of esophageal cancer.

Authors:  Jason B Wheeler; Carolyn E Reed
Journal:  Surg Clin North Am       Date:  2012-08-20       Impact factor: 2.741

3.  Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial.

Authors:  Prateek Sharma; Alexander R Meining; Emmanuel Coron; Charles J Lightdale; Herbert C Wolfsen; Ajay Bansal; Monther Bajbouj; Jean-Paul Galmiche; Julian A Abrams; Amit Rastogi; Neil Gupta; Joel E Michalek; Gregory Y Lauwers; Michael B Wallace
Journal:  Gastrointest Endosc       Date:  2011-07-13       Impact factor: 9.427

4.  Family history and the risk of stomach and colorectal cancer.

Authors:  C La Vecchia; E Negri; S Franceschi; A Gentile
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

5.  Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.

Authors:  Tatiana Benaglia; Linda D Sharples; Rebecca C Fitzgerald; Georgios Lyratzopoulos
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

6.  Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992-2009 SEER data.

Authors:  Felix H Lui; Bertrand Tuan; Sara L Swenson; Robert J Wong
Journal:  Dig Dis Sci       Date:  2014-07-17       Impact factor: 3.199

Review 7.  Screening and surveillance for gastric cancer in the United States: Is it needed?

Authors:  Gwang Ha Kim; Peter S Liang; Sung Jo Bang; Joo Ha Hwang
Journal:  Gastrointest Endosc       Date:  2016-03-03       Impact factor: 9.427

8.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Association between Habitual Dietary Salt Intake and Risk of Gastric Cancer: A Systematic Review of Observational Studies.

Authors:  Sheng Ge; Xiaohui Feng; Li Shen; Zhanying Wei; Qiankun Zhu; Juan Sun
Journal:  Gastroenterol Res Pract       Date:  2012-10-22       Impact factor: 2.260

View more
  6 in total

1.  Establish a Scoring Model for High-Risk Population of Gastric Cancer and Study on the Pattern of Opportunistic Screening.

Authors:  Wei Tao; Hai-Xia Wang; Yu-Feng Guo; Li Yang; Peng Li
Journal:  Gastroenterol Res Pract       Date:  2020-09-30       Impact factor: 2.260

2.  CMIP is oncogenic in human gastric cancer cells.

Authors:  Jianlin Zhang; Jin Huang; Xingyu Wang; Weidong Chen; Qinqing Tang; Maoyong Fang; Yeben Qian
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

3.  Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program.

Authors:  Negar Ahmadi; Lawrence Mbuagbaw; Waël C Hanna; Christian Finley; John Agzarian; Chuck K Wen; Michal Coret; Colin Schieman; Yaron Shargall
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

Review 4.  Advances in optical gastrointestinal endoscopy: a technical review.

Authors:  Yubo Tang; Sharmila Anandasabapathy; Rebecca Richards-Kortum
Journal:  Mol Oncol       Date:  2020-09-19       Impact factor: 6.603

Review 5.  The Use of miRNAs in Predicting Response to Neoadjuvant Therapy in Oesophageal Cancer.

Authors:  Cameron C J Lang; Megan Lloyd; Said Alyacoubi; Saqib Rahman; Oliver Pickering; Tim Underwood; Stella P Breininger
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

6.  Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.

Authors:  Danping Sun; Mingxiang Zhang; Meng Wei; Zhaoyang Wang; Wen Qiao; Peng Liu; Xin Zhong; Yize Liang; Yuanyuan Chen; Yadi Huang; Wenbin Yu
Journal:  Aging (Albany NY)       Date:  2022-05-04       Impact factor: 5.955

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.